Abstract: Pomegranate extracts and methods of use thereof are provided. Particularly, an antioxidative composition comprising an extract from pomegranate is provided. A method of reducing lipid peroxidation, aggregation or retention, HDL oxidation in a sample and a method of alleviating atherosclerosis in a patient are also provided.

Abstract: A hair cosmetic composition having an excellent hair setting property, and which imparts to hair good flexibility and a good finish feeling. The hair cosmetic composition comprises (a) a water-soluble amine-oxide-containing polymer having a weight-average molecular weight of 10,000 to 500,000 and (b) a water-soluble polymer selected from the group consisting of nonionic, cationic, anionic and amphoteric polymers. The weight ratio of component (a) to component (b) falls within a range of from 1:10 to 10:1. Components (a) and (b) are incorporated in a total amount of from 0.1 to 10 wt. % based on the hair cosmetic composition.

Abstract: A gelatinous composition comprising (i) at least one silicone oil, (ii) at least one specified polyether-modified silicone (iii) water, and (iv) at least one lower alcohol, which exhibit excellent stability with the elapse of time as well as good spreadability and good cosmetic persistency.

Abstract: Compositions comprising, in an aqueous phase, at least one amphiphilic polymer comprising at least one fatty chain and hydrophilic units, and at least one polyoxyalkylene, and optionally comprising a thickening system for use in particular in cosmetics.

Abstract: The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble &bgr;-glucan composition comprising &bgr;-glucan molecules having an average molecular weight of at least 1,000,000 daltons, as determined by multi-angle laser light scattering (VHMW-glucan).

Abstract: Composition and methods that include potassium nitrate for whitening and/or reducing tooth sensitivity. The dental compositions may optionally include a dental bleaching agent, such as hydrogen peroxide or carbamide peroxide. The dental compositions may be applied directly to the person's teeth, or they may be loaded into a comfortable fitting, flexible, thin-walled dental tray and placed over the person's teeth. In that case, the dental compositions will include a tackifying agent, such as carboxypolymethylene, dispersed within a solvent, which assists the composition in retaining the dental tray over the person's teeth as a result of the adhesive properties of the dental composition rather than due to mechanical interlocking of the tray over the person's teeth. The dental compositions may further include anticariogenic and antimicrobial agents.

Abstract: A polymeric carrier for delivery of bioactive or bioreactive molecules is provided, including a stereocomplex of one or more biocompatible polymers and having incorporated on or within the complex the molecules to be delivered. In a preferred embodiment, the biocompatible stereoselective polymers are linear or branched D-PLA homo- and block-polymers, linear or branched L-PLA homo- and block-polymers, copolymers thereof, or mixtures thereof, in stereocomplexed form. In one preferred embodiment, the polymeric carrier is complexed with a complementary stereospecific bioactive molecule. In other embodiments, the bioactive, or bioreactive (for example, for use in diagnostic applications), is bound to the complex by ionic, hydrogen, or other non-covalent binding reactions not involving stereocomplexation, or is physically entrapped within the complex, either at the time of complex formation or when the polymeric material is formulated into particles, tablets, or other form for pharmaceutical application.

Abstract: Pharmaceutical gel formulations for topical drug delivery include drug, colloidal silicon dioxide, triacetin and, preferably, propylene glycol. The gel formulations are well suited for topical delivery of the drug 4-amino-2-ethoxymethyl-&agr;,&agr;-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol, which when applied topically induces cytokines, such as interferon and tumor necrosis factor, locally in the skin or mucous membranes of a mammal. The gel formulations are also well-suited for topical delivery of drugs for treatment of diseases involving skin and/or mucosal lesions because the gel formulations do not need to include irritating components.

Abstract: A viscous gel for delivering minor effective homeopathic amount of zinc or another metal to the nasal membrane.

Abstract: Pharmaceutical dental gel preparation comprising of metronidazole benzoate, chlorhexidine gluconate, and local anesthetic as the active ingredient; glycol as the solvent medium; a carboxyvinyl polymer, cross-linked polymer of acrylic acid copolymerized with polyalkylsucrose as a gelling agent.

Abstract: Pomegranate extracts and methods of use thereof are provided. Particularly, an antioxidative composition comprising an extract from pomegranate is provided. A method of reducing lipid peroxidation, aggregation or retention, HDL oxidation in a sample and a method of alleviating atherosclerosis in a patient are also provided.

Abstract: A pharmaceutical composition has a blend of at least first and second components and a medicament in a sufficient amount to be therapeutic where the first component is hydroxypropylcellulose (HPC) and the second component is at least one other polymer selected from the group consisting of methylcellulose (MC), ethylhydroxyethylcellulose (EHEC), hydroxyethylmethylcellulose (HEMC), hydrophobically modified hydroxyethylcellulose (HMHEC), hydrophobically modified ethylhydroxyethylcellulose (HMEHEC), carboxymethylhydroxyethylcellulose (CMHEC), carboxymethyl hydrophobically modified hydroxyethylcellulose (CMHMHEC), guar, pectin, carrageenan, agar, algin, gellan gum, acacia, starch and modified starches, co-polymers of carboxyvinyl monomers, co-polymers of acrylate or methacrylate monomers, mono- and co-polymers of oxyethylene and oxypropylene and mixtures thereof and a medicament in a sufficient amount to be therapeutic, with the proviso that low-substituted hydroxypropylcellulose (L-HPC) is excluded from said firs

Abstract: A water/oil/water triple emulsion comprising an aqueous external phase and a W/O primary emulsion comprising an oily phase and an aqueous internal phase, which comprises at least one partially or completely crosslinked organopolysiloxane elastomer comprising a polyoxyethylenated and/or polyoxypropylenated chain. The emulsion may be used, for example for cleansing and/or treating and/or protecting the skin and/or mucous membranes and/or keratinous fibers.

Abstract: Gasified particles for cosmetic treatments, particularly hair treatments, are described. The gasified particles contain at least one gas enclosed in a solid enveloping material. The enveloping material is selected so that the gas is released on contact of the enveloping material with water or moisture. The release of the gas can be accompanied by a detectable acoustic effect (pop effect). The hair treatment composition also can provide a hair fixing effect. Furthermore an instant gel preparation is described substantially comprising a mixture of dry substances, which contains at least one gel former and at least one solid substance producing a detectable acoustic effect on contact with moisture, especially gasified particles. The gasified particles are used as acoustic indicators for the readiness of the instant preparation after liquid addition.

Abstract: A liniment is disclosed for use in conjunction with massage or other manual topical application method, and is adapted for any application where massage therapy is used as a part of a medically recommended treatment, particularly where pain management is involved. The liniment for topical application includes a mixture of ethyl alcohol, methyl hydrate and distilled water. To this solution is added horseradish and powdered cayenne pepper. The mixture is sealed for 25 days, with twice daily stirring or shaking. The particulate matter is allowed to settle for 3 days, after which the liniment is siphoned off for use. The liniment may be applied topically to the skin in areas of pain and discomfort.

Abstract: A cosmetic composition for skin use which comprises urea and a buffer comprising disodium hydrogenphosphate and citric acid or a buffer comprising potassium dihydrogenphosphate and disodium hydrogenphosphate, or both, and a cosmetic composition further comprising allantoin. Notwithstanding inclusion of urea which is useful for preventing rough dry skin and maintaining moisturization, the cosmetic composition does not have problems such as an increase in pH and an odor from ammonia produced by urea during storage for a long period of time.

Abstract: An effective and gentle formulation for the treatment and prevention of pseudofolliculitis barbae and skin irritation and method for the application of same is provided herein. In its preferred embodiment, the formulation consisting essentially of a petroleum balance containing 10% to 20% camphor, 5% fragrance oil and 1% to 2% mineral oil. The formulation is designed to prevent the razor bumps associated with pseudofolliculitis barbae without the use of harsh chemical compounds while allowing the user to continue to use a traditional method of shaving. The formulation is applied through a method consisting of shaving normally with a razor, application of a thin veneer of the formulation to the shaved area and removal of the formulation by means of a wet washcloth or other means.

Abstract: A composition for use as a post-foaming shaving gel, for example, comprising about 3% to about 20% by weight of the composition of a surfactant system, about 0.05% to about 10% by weight of the composition of poly(ethylene oxide) and polyvinylpyrrolidone, in a combined amount, wherein the poly(ethylene oxide) and the polyvinylpyrrolidone are present in a weight ratio of about 1:10 to about 10:1, and about 0.1% to about 10% by weight of the composition of a post-foaming agent.

Abstract: An effective poison bait composition is provided for the control of such objective pests as cockroaches, wherein the poison bait composition comprises (1) a pesticidally effective amount of a pesticidally active ingredient, (2) a carrageenan, and (3) glycerin. A methods of controlling objective pests is also provided, which utilizes the provided poison bait.

Abstract: The invention is of a topical medicament and associated methodology for use thereof, through the use of which fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations or fibrosis of muscle tissue may be effectively, cost effectively, and painlessly treated. One or more calcium channel blocker agents serve as the primary active ingredient of the present compositions, with carrier agents facilitating non-invasive transdermal delivery of the calcium channel blocker(s) to subdermal disease sites.

Abstract: A method of increasing glutathione levels in mammalian cells comprising administering an oral bolus of encapsulated pharmaceutically stabilized glutathione in a rapidly dissolving formulation to a mammal on an empty stomach. Pharmaceutical formulations including glutathione are also disclosed.

Abstract: This invention provides a milk lotion, cream or the like which does not undergo oil-water phase separation but remains stable for a long time and, in addition, has a good skin feel with good spreadability. It is a water-in-oil emulsifier composition comprising liquid oil basis, liquid oil component gelling agent, water and, as a water-in-oil type surfactant, polyglycerin fatty acid ester and/or polyoxyethylene hydrogenated castor oil.

Abstract: An oil/water/oil triple emulsion is stabilized with at least one partially or completely crosslinked organopolysiloxane elastomer having at least one polyoxyethylenated and/or polyoxypropylenated chain. The stable triple emulsion can be used as a composition for topical application, in particular as a cosmetic or dermatological composition, and especially as a vehicle for active principles. The emulsion is particularly useful for cleansing and/or treating and/or protecting the skin and/or mucous membranes and/or keratinous fibers.

Abstract: A clarified algae extract used to obtain a composition having antibacterial and/or antifungal activity, said extract being obtained according to a method comprising the stages of release of the intracellular content of the algae cells and clarification by filtration of said intracellular content, in order to obtain a clarified filtration permeate, said extract comprising a molecular fraction containing halogenated organic molecules having a molecular weight of more than 10,000.

Abstract: Use of a composition having an oil phase, an aqueous phase, at least one emulsifier of water-in-oil (W/O) type and at least one emulsifier of oil-in-water (O/W) type, in the form of a reverse latex comprising from 20% to 70% by weight, and preferably from 25% to 40% by weight, of an anionic polyelectrolyte, the anionic polyelectrolyte being based on partially neutralized acrylic acid, which may be branched and/or crosslinked, to prepare a cosmetic, dermopharmaceutical or pharmaceutical composition. Novel lattices, process for their preparation and cosmetic, dermopharmaceutical or pharmaceutical composition incorporating them.

Abstract: Balanced pH, thermo-irreversible gels are ideal vehicles for drug delivery to a body cavity of a mammal. The gels contain a mixture of a polyoxyalkylene block copolymer or polyether together with an ionic polysaccharide which is thermo-irreversibly gelled in the presence of a counter-ion.

Abstract: Carbomer or cross-polyacrylate polymers which are conventionally provided in a powdered form are converted to a granulated, pelletized or tablet form for subsequent use, in combination with a liquid medium, to form a gel from which products such as liquid detergents, cosmetics and toiletries can be produced. Conversion of the polymer into a granular, pelletized or tablet form has been demonstrated to improve handling of the dry polymer, thereby mitigating against many of the problems incurred with the use of conventional powders, as well as to improve the rate of blending of the polymer with a liquid medium. In some embodiments, the polymer is blended with an electrolyte which may be a salt, acid or acid salt having a pK which is at least 1 unit, and preferably 2 units, greater than the pK of the polymer.

Abstract: Methods and apparatus for improving administration of drugs through the use of heat and other physical means. The present invention relates to the use of heat and other physical means in conjunction with specially designed dermal drug delivery systems, conventional commercial dermal drug delivery systems, or drugs delivered into a sub-skin depot site via injection and other methods to alter, mainly increase, the drug release rate from the dermal drug delivery systems or the depot sites to accommodate certain clinical needs.

Abstract: The present invention relates to sustained-release formulations using alginate gel beads and methods thereof.

Abstract: The invention relates to the use of aminoalcohol derivatives containing a urea functional group corresponding to the following formula: in which: R1 represents a linear or branched, saturated or unsaturated alkyl radical having from 8 to 22 carbon atoms; R2 represents a hydrogen atom or a linear or branched, saturated alkyl radical having from 1 to 6 carbon atoms; R3 represents a linear or branched, monohydroxylated or polyhydroxylated, saturated alkyl group having from 1 to 10 carbon atoms, in and for the preparation of cosmetic or dermatological compositions. These compounds are used in particular as moisturizing agents in care products for the skin or as conditioning agents in hair products.

Abstract: The present invention relates to a collagen gel, its production process, a medical material in which it is used or a kit for its production, wherein said collagen gel is obtained by crosslinking collagen with polyanion and carbodiimide.

Abstract: Disclosed are methods for treating AVMs in a mammal by use of a radiation composition.

Abstract: This invention relates to the topical and oral treatment of hair loss, especially androgenic alopecia, by providing formulations that include anti-androgens, especially extracts of the saw palmetto plant, co-enzyme Q, and acetyl carnitine, and optionally stimulators of adenylate cyclase to stimulate hair growth, to increase the luster of hair, and to decrease hair graying.

Abstract: A cosmetic or dermatological composition, comprising: an aqueous phase dispersed in an oily phase with a silicone emulsifying agent, wherein the viscosity of the composition, measured with a Rheomat 180 viscometer at a shear rate of 200 s−1 and at 25° C., ranges from 3 Pa.s (30 poises) to 20 Pa.

Abstract: The pigment-containing foamable gel for temporarily coloring the hair contains from 35 to 98 percent by weight water; one or more gel-forming thickener that imparts a yield point to the composition; at least one pigment; at least one film-forming, hair-fixing polymer; at least one foam-producing surfactant and at least one propellant, in combination with a suitable aerosol package and a foam-forming device for foaming the gel. The concentration of the thickener or thickeners in the gel is selected so that, on the one hand, the viscosity of the gel is sufficiently reduced so that foaming of the gel is possible and, on the other hand, the yield point is at least large enough so that settling of the pigment is prevented. The easily foamable composition has a hair-fixing effect and temporarily colors the hair, providing a high color brilliance and lustrous appearance. The composition is washable from the hair at will and the color of the hair provided by it has good fastness to rubbing.

Abstract: This invention relates to a bioavailable oral dosage form comprising of amorphous cefuroxime axetil containing from 7 to 25% crystalline cefuroxime axetil.

Abstract: Crushable gel beads 10 formed of an agar complex provide novel cosmetic, pharmaceutical, etc. delivery vehicles for topical delivery of biologically or cosmetically active agents. Preferred agar beads 10 are complexes of a continuous phase of agar gel 12 in a self-supporting solid or semi-solid form with a restraining polymer 14. Entrapped in and dispersed randomly throughout each agar bead 10 is a water-soluble, preferably polar, restraining polymer 14, preferably a quaternized cationic polymer, such as polyquaternium 24 or steardimonium hydroxyethylcellulose. Various active agents 16 may be bound to restraining polymer 14, for example ascorbic acid, lactic acid or papain. Methods of manufacture are also described.

Abstract: Contact lens care compositions for the treatment of hard contact lenses arc disclosed. The compositions are useful for rinsing, cleaning, disinfecting and storing of hard contact lenses. The compositions contain an unique gelling system involving galactomannan polysaccharides and borates to allow for the conditioning of the lens when it is reinserted in the eye of the user. Methods of using these compositions are also disclosed.

Abstract: The present invention comprises methods and compositions for topically treating and moisturizing keratinous structures of humans and animals including skin, hair, fingernails, toenails, hooves, and horns.

Abstract: The present invention relates to a solid composition for topical application, which is free of fillers, containing, in an aqueous phase, less than 20% of the total weight of the composition of a hydrophillic gelling system having the combination of at least 2% by weight of kappa-carrageenan, relative to the total weight of the composition, and at least one hydrocolloid chosen from xanthan gum and cellulose derivatives which are soluble in hot water.

Abstract: There is provided a cosmetic composition, preferably in the form of a lip gloss composition, that is smooth, glossy, and wear resistant. The composition has an oil or liquid ester and a gel, and optionally, one or more waxes, one or more pigments, and one or more emollients.

Abstract: The present invention pertains to the use of a cosmetically and dermatologically well-tolerated organic compound containing activated oxygen for preparing a preparation for improving the microcirculation of the skin.

Abstract: Composition and methods that include potassium nitrate for whitening and/or reducing tooth sensitivity. The dental compositions may optionally include a dental bleaching agent, such as hydrogen peroxide or carbamide peroxide. The dental compositions may be applied directly to the person's teeth, or they may be loaded into a comfortable fitting, flexible, thin-walled dental tray and placed over the person's teeth. In that case, the dental compositions will include a tackifying agent, such as carboxypolymethylene, dispersed within a solvent, which assists the composition in retaining the dental tray over the person's teeth as a result of the adhesive properties of the dental composition rather than due to mechanical interlocking of the tray over the person's teeth. The dental compositions may further include anticariogenic and antimicrobial agents.

Abstract: Methods and apparatus for improving administration of drugs through the use of heat and other physical means. The present invention relates to the use of heat and other physical means in conjunction with specially designed dermal drug delivery systems, conventional commercial dermal drug delivery systems, or drugs delivered into a sub-skin depot site via injection and other methods to alter, mainly increase, the drug release rate from the dermal drug delivery systems or the depot sites to accommodate certain clinical needs.

Abstract: The present invention teaches that daily, cyclical vaginal delivery of progestin may be used to provide regular, predictable withdrawal bleeding during hormone replacement therapy. The present invention also teaches that constant administration of progestin in a water-insoluble, water-swellable cross-linked polycarboxylic acid polymer may be used to maintain amenorrhea. Either regimen is accompanied by a significant decrease in adverse side effects.

Abstract: The present invention relates to stable aqueous formulations of the insect repellent ethyl 3-(N-butyl-acetamino)propionate.

Abstract: Composition and methods that include potassium nitrate for whitening and/or reducing tooth sensitivity. The dental compositions may optionally include a dental bleaching agent, such as hydrogen peroxide or carbamide peroxide. The dental compositions may be applied directly to the person's teeth, or they may be loaded into a comfortable fitting, flexible, thin-walled dental tray and placed over the person's teeth. In that case, the dental compositions will include a tackifying agent, such as carboxypolymethylene, which assists the composition in retaining the dental tray over the person's teeth as a result of the adhesive properties of the dental composition rather than due to mechanical interlocking of the tray over the person's teeth. The dental compositions may further include anticariogenic and antimicrobial agents.

Abstract: Methods and apparatus for improving administration of drugs through the use of heat and other physical means. The present invention relates to the use of heat and other physical means in conjunction with specially designed dermal drug delivery systems, conventional commercial dermal drug delivery systems, or drugs delivered into a sub-skin depot site via injection and other methods to alter, mainly increase, the drug release rate from the dermal drug delivery systems or the depot sites to accommodate certain clinical needs.

Abstract: A method of producing a melanin comprises oxidizing a phenolic compound at one or more hydroxyl groups thereof, wherein the phenolic compound is selected from 5-hydroxyindole and derivatives thereof and compounds of formula (1) and the oxidation is provided by biotransformation in the presence of an oxidoreductase enzyme, the compound of formula (1), wherein R1 is H or OH; R2 is H, OH orOCH3; R3 is H or OH at least one of R1 and R3 being OH; R4 is selected from H , R, —COOX and R7—COOX, wherein R is an optionally substituted saturated or unsaturated alkyl group having from 1 to 12 carbon atoms, R7 is an optionally substituted saturated or unsaturated alkylene group having from 1 to 12 carbon atoms and X is selected from H and aliphatic and aromatic ester forming groups; and R5 and R6 is each independently selected from H, OH, NH2, OCH3, CH3, SH, NHCO2, NHCH3, COOH and saturated or unsaturated alkyl groups having up to 8 carbon atoms.

Abstract: A composition and method of treating cutaneous infection and resulting inflammation in animals known as hot spots and mange, respectively, as well as related veterinarian dermatological conditions. The composition includes L-glutathione and a source of selenium which act synergistically and which are included in a suitable topical carrier for topical application.